Fujita M - Search Results

1

Clinical efficacy and safety of cefepime in febrile neutropenic patients with lung cancer.

Fujita M, Ouchi H, Inoue Y, Inoshima I, Ohshima T, Yoshimura C, Wataya H, Kawasaki M, Tokunaga S, Nakanishi Y; Lung Oncology Group in Kyushu (LOGIK). Fujita M, et al. J Infect Chemother. 2010 Apr;16(2):113-7. doi: 10.1007/s10156-010-0030-3. Epub 2010 Feb 4. J Infect Chemother. 2010. PMID: 20130951 Clinical Trial.

2

P53 and p21 (Waf1/Cip1) mRNA expression associated with DNA damage and repair in acute immune complex alveolitis in mice.

Kuwano K, Hagimoto N, Nomoto Y, Kawasaki M, Kunitake R, Fujita M, Miyazaki H, Hara N. Kuwano K, et al. Among authors: fujita m. Lab Invest. 1997 Feb;76(2):161-9. Lab Invest. 1997. PMID: 9042152

3

Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen.

Hagimoto N, Kuwano K, Miyazaki H, Kunitake R, Fujita M, Kawasaki M, Kaneko Y, Hara N. Hagimoto N, et al. Among authors: fujita m. Am J Respir Cell Mol Biol. 1997 Sep;17(3):272-8. doi: 10.1165/ajrcmb.17.3.2893. Am J Respir Cell Mol Biol. 1997. PMID: 9308912

4

Expression of B7-1, B7-2, and interleukin 12 in bleomycin-induced pneumopathy in mice.

Kaneko Y, Kuwano K, Hagimoto N, Miyazaki H, Kawasaki M, Fujita M, Kunitake R, Maeyama T, Hara N. Kaneko Y, et al. Among authors: fujita m. Int Arch Allergy Immunol. 1998 Aug;116(4):306-12. doi: 10.1159/000023960. Int Arch Allergy Immunol. 1998. PMID: 9693281

5

Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung diseases.

Kunitake R, Kuwano K, Miyazaki H, Kawasaki M, Hagimoto N, Fujita M, Kaneko Y, Hara N. Kunitake R, et al. Among authors: fujita m. Eur Respir J. 1998 Oct;12(4):920-5. doi: 10.1183/09031936.98.12040920. Eur Respir J. 1998. PMID: 9817169 Free article. Clinical Trial.

6

Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice.

Fujita M, Kuwano K, Kunitake R, Hagimoto N, Miyazaki H, Kaneko Y, Kawasaki M, Maeyama T, Hara N. Fujita M, et al. Int Arch Allergy Immunol. 1998 Nov;117(3):202-8. doi: 10.1159/000024011. Int Arch Allergy Immunol. 1998. PMID: 9831808

7

The involvement of Fas-Fas ligand pathway in fibrosing lung diseases.

Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kunitake R, Kaneko Y, Hara N. Kuwano K, et al. Among authors: fujita m. Am J Respir Cell Mol Biol. 1999 Jan;20(1):53-60. doi: 10.1165/ajrcmb.20.1.2941. Am J Respir Cell Mol Biol. 1999. PMID: 9870917

8

Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases.

Kuwano K, Maeyama T, Inoshima I, Ninomiya K, Hagimoto N, Yoshimi M, Fujita M, Nakamura N, Shirakawa K, Hara N. Kuwano K, et al. Among authors: fujita m. Respirology. 2002 Mar;7(1):15-21. doi: 10.1046/j.1440-1843.2002.00369.x. Respirology. 2002. PMID: 11896896

9

TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells.

Hagimoto N, Kuwano K, Inoshima I, Yoshimi M, Nakamura N, Fujita M, Maeyama T, Hara N. Hagimoto N, et al. Among authors: fujita m. J Immunol. 2002 Jun 15;168(12):6470-8. doi: 10.4049/jimmunol.168.12.6470. J Immunol. 2002. PMID: 12055267

10

[A case of papulonecrotic tuberculide preceded by pulmonary tuberculosis].

Fujita M, Nakanishi Y, Yoshida K, Hamada N, Kuwano K. Fujita M, et al. Kansenshogaku Zasshi. 2002 Jul;76(7):558-61. doi: 10.11150/kansenshogakuzasshi1970.76.558. Kansenshogaku Zasshi. 2002. PMID: 12212322 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,405 results

Search Page

Filters